Literature DB >> 2535741

Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.

W J Britt1, L G Vugler.   

Abstract

The processing pathway of the major envelope glycoprotein complex, gp55-116 (gB), of human cytomegalovirus was studied using inhibitors of glycosylation and endoglycosidases. The results of these studies indicated that the mature gp55-116 is synthesized by the addition of both simple and complex N-linked sugars to a nonglycosylated precursor of estimated Mr 105,000. In a rapid processing step, the Mr 105,000 precursor is glycosylated to a protein of Mr 150,000 (gp150) which contains only endoglycosidase H-sensitive sugar linkages. The gp150 is then processed relatively slowly to a Mr 165,000 to 170,000 species (gp165-170), which is then cleaved to yield the mature gp55-116. Monensin prevented the final processing steps of the gp150, including cleavage, suggesting that transport through the Golgi apparatus is required for complete processing. Digestion of the intracellular forms of this complex as well as the virion forms confirmed the above findings and indicated that the mature virion form of gp55 contains 8,000 daltons of N-linked sugars. The virion gp116 contains some 52,000 to 57,000 daltons of N-linked carbohydrates and approximately 5,000 daltons of O-linked sugars.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535741      PMCID: PMC247697     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

2.  Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  Virus Res       Date:  1985-12       Impact factor: 3.303

3.  Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex.

Authors:  N Lukàcs; H J Thiel; T C Mettenleiter; H J Rziha
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Characterization of the human cytomegalovirus envelope glycoproteins.

Authors:  G H Farrar; J D Oram
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

5.  Human cytomegalovirus virion-associated protein with kinase activity.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

6.  Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus.

Authors:  L Rasmussen; J Mullenax; R Nelson; T C Merigan
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

7.  Human cytomegalovirus: glycoproteins associated with virions and dense bodies.

Authors:  M F Stinski
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

8.  Mapping of the major glycoprotein gene of human cytomegalovirus.

Authors:  M Mach; U Utz; B Fleckenstein
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

9.  Effect of tunicamycin and monensin on biosynthesis, transport, and maturation of bovine herpesvirus type-1 glycoproteins.

Authors:  S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  Processing of virus-specific glycoproteins of varicella zoster virus.

Authors:  J Namazue; H Campo-Vera; K Kitamura; T Okuno; K Yamanishi
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

View more
  54 in total

1.  A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.

Authors:  B Wagner; B Kropff; H Kalbacher; W Britt; V A Sundqvist; L Ostberg; M Mach
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells.

Authors:  Jessica Sorem; Richard Longnecker
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

4.  Cytomegalovirus-specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection.

Authors:  J van Zanten; M van der Giessen; L H van der Voort; W J van Son; W van der Bij; T H The
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

5.  Anti-idiotypic mimicry of a neutralizing epitope on the glycoprotein B complex of human cytomegalovirus.

Authors:  E S Tackaberry; J Hamel; Y Larose; B R Brodeur
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.

Authors:  M A Billstrom; W J Britt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.

Authors:  Y Yamashita; K Shimokata; S Saga; S Mizuno; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1.

Authors:  I Rauh; F Weiland; F Fehler; G M Keil; T C Mettenleiter
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus.

Authors:  A Kopp; E Blewett; V Misra; T C Mettenleiter
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.

Authors:  Y Yamashita; K Shimokata; S Mizuno; T Daikoku; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.